BDWM
AZN icon

Brewin Dolphin Wealth Management’s AstraZeneca AZN Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-21
Closed -$3K – 348
2022
Q1 		$3K Buy
+21
New +$2.52K ﹤0.01% 342

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brewin Dolphin Wealth Management's AZN Position: Q2 2022 in Review

Brewin Dolphin Wealth Management sold out of AstraZeneca (AZN) in Q2 2022, closing a stake of 21 shares — an estimated $3K sold.

Brewin Dolphin Wealth Management first reported a position in AZN in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 1,015 funds tracked by Wall St. Rank hold AZN as of Q2 2022.

  • Brewin Dolphin Wealth Management reported no remaining AstraZeneca position as of Q2 2022 after selling out during the quarter.
  • Brewin Dolphin Wealth Management sold 21 AstraZeneca shares in Q2 2022, an estimated $3K.
  • Brewin Dolphin Wealth Management first reported a position in AstraZeneca in Q1 2022 and held it in 1 quarter.
  • Brewin Dolphin Wealth Management's AstraZeneca position peaked at $3K in Q1 2022.
  • 1,015 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.